{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:02:40Z","timestamp":1767211360309,"version":"3.41.2"},"reference-count":19,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":325,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Anemia"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Sickle cell emergencies are the most common cause of hospitalization for patients with sickle cell disease (SCD). Hospital readmissions represent a considerable financial burden for healthcare systems and increase patient morbidity and mortality. The aim of this study was to assess the prevalence and predictive factors of sickle cell emergencies readmission.<\/jats:p><jats:p><jats:bold>Materials and Methods:<\/jats:bold> We conducted a prospective, cross\u2010sectional, descriptive, and analytical study over a 4\u2010month period, including all adult patients admitted for an emergency related to SCD: vaso\u2010occlusive crisis (VOC), acute chest syndrome (ACS), severe anemia, infections, priapism, and stroke. Readmission was considered when the patient returned to the emergency within a period of &lt;30\u2009days, either due to recurrence, persistence of the same complication, or the occurrence of another acute complication related to SCD.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> We recorded 151 sickle cell emergencies for 112 patients, representing 0.33 emergencies\/month\/patient. Fifty\u2010eight cases of readmission were recorded, resulting in a readmission rate of 38.41%. Among these patients, 53 (91.37%) had two admissions, and 5 (8.62%) had three admissions. The median age of the patients was 28.41\u2009years (16\u201370\u2009years), and the sex ratio was 0.57. The SS sickle cell phenotype was predominant in 97 patients (86.61%). The reasons for readmission were VOC (82.75%), ACS (13.72%), and severe anemia (3.44%). The main factors that predicted readmission were the existence of professional activity, a low fetal hemoglobin (HbF) level, the existence of neutrophilia, lymphocytosis, and\/or thrombocytosis (<jats:italic>p<\/jats:italic> values of 0.0084, 0.043, and 0.020 respectively).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The 30\u2010day readmission rate after a sickle cell emergency is high in our study. The main factors that predicted readmission were the existence of professional activity, a relatively low level of fetal Hb, the existence of neutrophilia, lymphocytosis, and\/or thrombocytosis.<\/jats:p>","DOI":"10.1155\/anem\/7143716","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T13:18:59Z","timestamp":1732195139000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and Predictive Factors of Sickle Cell Emergencies Readmission in the Clinical Hematology Department of Dakar, Senegal"],"prefix":"10.1155","volume":"2024","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0620-873X","authenticated-orcid":false,"given":"Alioune Badara","family":"Diallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-6707","authenticated-orcid":false,"given":"Moussa","family":"Seck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0251-1368","authenticated-orcid":false,"given":"Sokhna Aissatou","family":"Tour\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4100-4684","authenticated-orcid":false,"given":"Mohamed","family":"Keita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3148-4289","authenticated-orcid":false,"given":"Elimane Seydi","family":"Bousso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7066-7984","authenticated-orcid":false,"given":"Blaise F\u00e9lix","family":"Faye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2354-3839","authenticated-orcid":false,"given":"Saliou","family":"Diop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"e_1_2_9_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30193-9"},{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.10"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.378"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-132215"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20336"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.12.010"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.2471\/blt.06.036673"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.273"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpem.2018.05.005"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2016.05.042"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58934-3"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2018.01.014"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1155-1984(09)49949-7"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.4314\/gmj.v49i2.7"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V41.1.59.59"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1997.02170450109022"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2019.02.010"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2011.028"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2019.042"}],"container-title":["Anemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/anem\/7143716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T13:19:02Z","timestamp":1732195142000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/anem\/7143716"}},"subtitle":[],"editor":[{"given":"Duran","family":"Canatan","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1155\/anem\/7143716"],"URL":"https:\/\/doi.org\/10.1155\/anem\/7143716","archive":["Portico"],"relation":{},"ISSN":["2090-1267","2090-1275"],"issn-type":[{"type":"print","value":"2090-1267"},{"type":"electronic","value":"2090-1275"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2024-03-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"7143716"}}